Effects of vaccines on clinical characteristics of convalescent adult patients infected with SARS-CoV-2 Omicron variant: A retrospective study

Abstract

IntroductionThe protective effect of SARS-CoV-2 vaccines has become a global focus due to Omicron variant pandemic. The effects of various SARS-CoV-2 vaccines are diverse. However, studies on the effect of domestic vaccines on clinical characteristics in convalescent adult patients infected with the Omicron variant are lacking.MethodsIn this retrospective, single-center cohort study, the effect of three domestic vaccines on clinical characteristics of convalescent adult patients infected with the Omicron variant was investigated in the initial largest outbreak of the Omicron variant infection between January and February 2022 in Tianjin, China. The primary endpoint was COVID-19 severity and the secondary endpoints were re-positive results on nucleic acid tests, liver and kidney function, and inflammation levels during recovery.ResultsA total of 320 adult patients infected with the Omicron variant were enrolled, including 296 post-vaccination and 24 unvaccinated patients. The median age of the unvaccinated patients was higher than that of vaccinated patients, but no significant difference was detected in the sex composition ratio between the different groups. Binary logistic regression results suggested that Sinopharm and Sinovac vaccine was an independent protective factor for relieving the severity of the Omicron variant infection. Regrettably, the vaccines did not showed any protective effect on the liver and kidney function of convalescent adult patients. Three domestic vaccines significantly relieved inflammation and increased the SARS-CoV-2-specific antibody levels. Furthermore, Sinovac and CanSino vaccines had a better immune stimulation effect on increasing T lymphocytes levels in convalescent adult patients. In addition, three domestic vaccines have protective effects on preventing re-detectable positive (RP) result in convalescent adult patients.ConclusionAlthough the three domestic vaccines cannot prevent the infection of the Omicron variant, it has a significant protective effect in adult patients. This study supports the policy of accelerating to vaccination worldwide combat the evolving and mutating SARS-CoV-2.DiscussionOmicron spreads faster and might escape antibodies more readily than previous variants, increasing the cases of reinfection and breakthrough infections in vaccinated people. Although vaccinated people are likely to have a much lower risk of severe disease from Omicron infection, many issues still need to be considered. Concerns about lower vaccine efficacy because of new variants might have changed our understanding of the COVID-19 endgame, disabusing the world of the notion that global vaccination is by itself adequate for controlling SARS-CoV-2 infection. The current data showed that vaccination with three domestic SARS-CoV-2 vaccines alleviates the disease severity of adult patients with COVID-19, reduces the inflammation level and the RP rate of convalescent adult patients, and enhances body’s defense against the virus in convalescent adult patients. Moreover, our study has highlighted that a combination prevention approach of vaccination and public health measures would be an effective strategy.

The Outcomes of Patients with Omicron Variant Infection who Undergo Elective Surgery: A Propensity-score-matched Case-control Study

“…Specifically, the most widely administered SARS-CoV-2 vaccine is the inactivated one in mainland China 35 . Although domestic vaccines may not provide complete protection against Omicron variants, they do offer significant safeguards for adult patients 36 . Wang J et al found that vaccinated adult patients had notably lower levels of Interleukin-6 and C-reactive protein compared to unvaccinated patients, revealing that the domestic vaccines provide significant protection against inflammation reduction in adult patients during the recovery phase 36 .…”

“…Although domestic vaccines may not provide complete protection against Omicron variants, they do offer significant safeguards for adult patients 36 . Wang J et al found that vaccinated adult patients had notably lower levels of Interleukin-6 and C-reactive protein compared to unvaccinated patients, revealing that the domestic vaccines provide significant protection against inflammation reduction in adult patients during the recovery phase 36 . In our study, over 90% of the patients had been vaccinated, which likely contributed to a notable reduction in the rate of perioperative complications.…”

“…Vaccination against COVID-19 stands as the most effective measure to reduce the severity of infection and minimize perioperative complications. Therefore, it is strongly encouraged to promote vaccination preoperatively 36 . Thus, Omicron variants exhibit high transmissibility but lower pathogenicity compared to other SARS-CoV-2 variants.…”